SanBio rides regenerative medicine wave in Japan

SanBio Co. Ltd. (Tokyo:4592) raised Y8 billion ($67.2 million) through the sale of 4 million shares at Y2,000 in an IPO, with the shares set to begin trading April 8 on the Tokyo Stock Exchange's Mothers.

The price values the cell therapy company at Y87.2 billion ($732.8 million). Last month, it proposed to sell 4 million shares at a to-be-determined price in the offering underwritten by Nomura; Mizuho; SBI Securities; and SMBC Nikko Capital Markets. ...